Barclays PLC Has $10.70 Million Stock Position in Balchem Co. (NASDAQ:BCPC)

Barclays PLC raised its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 405.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,777 shares of the basic materials company's stock after acquiring an additional 48,762 shares during the period. Barclays PLC owned approximately 0.19% of Balchem worth $10,695,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp increased its position in Balchem by 1.0% during the third quarter. State Street Corp now owns 1,234,226 shares of the basic materials company's stock worth $217,224,000 after acquiring an additional 12,006 shares during the period. Conestoga Capital Advisors LLC increased its holdings in shares of Balchem by 1.8% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company's stock worth $206,900,000 after purchasing an additional 20,360 shares during the period. Geneva Capital Management LLC increased its holdings in shares of Balchem by 1.7% during the 3rd quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company's stock worth $137,257,000 after purchasing an additional 12,750 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Balchem by 0.9% during the second quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company's stock valued at $107,372,000 after buying an additional 5,977 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of Balchem by 944.3% in the third quarter. FMR LLC now owns 497,495 shares of the basic materials company's stock valued at $87,559,000 after buying an additional 449,854 shares during the period. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Price Performance

BCPC stock traded down $3.93 during trading on Tuesday, hitting $172.35. The company had a trading volume of 349,333 shares, compared to its average volume of 110,787. The company has a fifty day moving average price of $175.26 and a two-hundred day moving average price of $169.44. Balchem Co. has a fifty-two week low of $135.84 and a fifty-two week high of $186.03. The company has a market cap of $5.60 billion, a P/E ratio of 46.33, a P/E/G ratio of 5.32 and a beta of 0.67. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Balchem Increases Dividend

The company also recently announced an annual dividend, which will be paid on Friday, January 17th. Stockholders of record on Thursday, December 26th will be issued a $0.87 dividend. This is a positive change from Balchem's previous annual dividend of $0.79. The ex-dividend date is Thursday, December 26th. This represents a dividend yield of 0.4%. Balchem's dividend payout ratio is presently 23.39%.

Wall Street Analysts Forecast Growth

Several research firms have commented on BCPC. HC Wainwright upped their price target on Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a report on Monday, November 4th. StockNews.com raised shares of Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.